Safety profile of blockbuster blood thinner comes under question

Wednesday, July 23, 2014 - 20:30 in Health & Medicine

A new investigation has raised fresh questions about a bestselling prescription medication to reduce stroke risk in those with the heart rhythm disorder known as atrial fibrillation.

Read the whole article on LA Times - Science

More from LA Times - Science

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net